speb/financial-data huggingface dataset:
BRNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 0.00
BRNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 451000.00
BRNS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -10726000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -1041000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: -573000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -504000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -156000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Payable: -1041000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: -1614000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 957000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Receivables: -145000.00
BRNS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1462000.00
BRNS cash_flow (quarterly, 2025-09-30) — Changes In Cash: -10275000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Common Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 84465000.00
BRNS cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
BRNS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 6373000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Current Assets: 86781000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 2017000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2017000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1402000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1402000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 10798000.00
BRNS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -71000.00
BRNS cash_flow (quarterly, 2025-09-30) — Deferred Tax: -71000.00
BRNS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 901000.00
BRNS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 901000.00
BRNS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 40661118.00
BRNS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.36
BRNS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -14566000.00
BRNS income_statement (quarterly, 2025-09-30) — EBIT: -14629000.00
BRNS income_statement (quarterly, 2025-09-30) — EBITDA: -13728000.00
BRNS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -1835000.00
BRNS cash_flow (quarterly, 2025-09-30) — End Cash Position: 75674000.00
BRNS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 0.00
BRNS balance_sheet (quarterly, 2025-09-30) — Foreign Currency Translation Adjustments: -15868000.00
BRNS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -10726000.00
BRNS cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: -68000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -15868000.00
BRNS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 5165000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 14909000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 6582000.00
BRNS income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 4667000.00
BRNS income_statement (quarterly, 2025-09-30) — Interest Expense: 13000.00
BRNS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 13000.00
BRNS income_statement (quarterly, 2025-09-30) — Interest Income: 472000.00
BRNS income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 472000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 84465000.00
BRNS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 451000.00
BRNS cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
BRNS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 9553000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 9553000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 96000.00
BRNS income_statement (quarterly, 2025-09-30) — Minority Interests: 5000.00
BRNS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
BRNS cash_flow (quarterly, 2025-09-30) — Net Foreign Currency Exchange Gain Loss: -1186000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Income: -14566000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -14566000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -14571000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -14566000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -14566000.00
BRNS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -14571000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -14571000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Interest Income: 459000.00
BRNS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 459000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Net PPE: 6582000.00
BRNS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 451000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 69556000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 320000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 320000.00
BRNS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -9061000.00
BRNS income_statement (quarterly, 2025-09-30) — Normalized Income: -9921630.58
BRNS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -10726000.00
BRNS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -1254000.00
BRNS income_statement (quarterly, 2025-09-30) — Operating Income: -10159000.00
BRNS income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BRNS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 40827263.00
BRNS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 663000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 86000.00
BRNS income_statement (quarterly, 2025-09-30) — Other Gand A: 5165000.00
BRNS income_statement (quarterly, 2025-09-30) — Other Income Expense: -4942000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 14909000.00
BRNS cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 1479000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 929000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 3969000.00
BRNS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -275000.00
BRNS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: -156000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Other Properties: 6582000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 4705000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Payables: 698000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 7071000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 308000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 5412000.00
BRNS income_statement (quarterly, 2025-09-30) — Pretax Income: -14642000.00
BRNS cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 0.00
BRNS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: 0.00
BRNS balance_sheet (quarterly, 2025-09-30) — Receivables: 4894000.00
BRNS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 901000.00
BRNS income_statement (quarterly, 2025-09-30) — Research And Development: 5150000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 1402000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -293002000.00
BRNS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5165000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Share Issued: 40827263.00
BRNS income_statement (quarterly, 2025-09-30) — Special Income Charges: -4667000.00
BRNS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: -415000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 84465000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 69556000.00
BRNS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -22630.58
BRNS income_statement (quarterly, 2025-09-30) — Tax Provision: -71000.00
BRNS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BRNS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 189000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Assets: 109201000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 84465000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Debt: 11570000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 84561000.00
BRNS income_statement (quarterly, 2025-09-30) — Total Expenses: 10159000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 24640000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 22420000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 13842000.00
BRNS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -15066000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
BRNS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -4667000.00
BRNS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -4667000.00
BRNS balance_sheet (quarterly, 2025-09-30) — Working Capital: 75983000.00
BRNS income_statement (annual, 2025-12-31) — +Operating Expense: 63888000.00
BRNS income_statement (quarterly, 2025-12-31) — +Operating Expense: 11449000.00
BRNS income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
BRNS income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Accounts Payable: 350000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 350000.00
BRNS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7591000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7591000.00
BRNS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 393944000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 393944000.00
BRNS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 5794000.00
BRNS cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 1127000.00
BRNS income_statement (annual, 2025-12-31) — Basic Average Shares: 40527218.00
BRNS income_statement (annual, 2025-12-31) — Basic EPS: -1.64
BRNS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 112400000.00
BRNS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 75674000.00
BRNS cash_flow (annual, 2025-12-31) — Capital Expenditure: -37000.00
BRNS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 11281000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 11281000.00
BRNS balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
BRNS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 70456000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 70456000.00
BRNS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 70456000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 70456000.00
BRNS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2000.00
BRNS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 0.00
BRNS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 416000.00
BRNS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2000.00
BRNS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -47979000.00
BRNS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -4242000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Account Payable: -2202000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -348000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -3793000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -453000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1979000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -502000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -506000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -8000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Payable: -2202000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Payable: -348000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -5995000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -801000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 1704000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 1278000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Receivables: 6417000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Receivables: 3471000.00
BRNS cash_flow (annual, 2025-12-31) — Change In Working Capital: -359000.00
BRNS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 3438000.00
BRNS cash_flow (annual, 2025-12-31) — Changes In Cash: -47561000.00
BRNS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -4240000.00
BRNS balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
BRNS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 74208000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 74208000.00
BRNS cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
BRNS cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 6249000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 6249000.00
BRNS balance_sheet (annual, 2025-12-31) — Current Assets: 77790000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Current Assets: 77790000.00
BRNS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 2023000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 2023000.00
BRNS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 2023000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 2023000.00
BRNS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1396000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1396000.00
BRNS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1396000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1396000.00
BRNS balance_sheet (annual, 2025-12-31) — Current Liabilities: 10018000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 10018000.00
BRNS cash_flow (annual, 2025-12-31) — Deferred Income Tax: -175000.00
BRNS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -57000.00
BRNS cash_flow (annual, 2025-12-31) — Deferred Tax: -175000.00
BRNS cash_flow (quarterly, 2025-12-31) — Deferred Tax: -57000.00
BRNS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 5845000.00
BRNS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 909000.00
BRNS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 5845000.00
BRNS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 909000.00
BRNS income_statement (annual, 2025-12-31) — Diluted Average Shares: 40527218.00
BRNS income_statement (annual, 2025-12-31) — Diluted EPS: -1.64
BRNS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -66428000.00
BRNS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -11090000.00
BRNS income_statement (annual, 2025-12-31) — EBIT: -66582000.00
BRNS income_statement (quarterly, 2025-12-31) — EBIT: -11147000.00
BRNS income_statement (annual, 2025-12-31) — EBITDA: -60737000.00
BRNS income_statement (quarterly, 2025-12-31) — EBITDA: -10238000.00
BRNS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 7013000.00
BRNS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 418000.00
BRNS cash_flow (annual, 2025-12-31) — End Cash Position: 71852000.00
BRNS cash_flow (quarterly, 2025-12-31) — End Cash Position: 71852000.00
BRNS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 2000.00
BRNS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: -15731000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: -15731000.00
BRNS cash_flow (annual, 2025-12-31) — Free Cash Flow: -48016000.00
BRNS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4242000.00
BRNS cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: -245000.00
BRNS cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 104000.00
BRNS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -15731000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -15731000.00
BRNS income_statement (annual, 2025-12-31) — General And Administrative Expense: 40830000.00
BRNS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 7642000.00
BRNS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 14288000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 14288000.00
BRNS balance_sheet (annual, 2025-12-31) — Gross PPE: 12752000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 12752000.00
BRNS income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 4667000.00
BRNS income_statement (quarterly, 2025-12-31) — Impairment Of Capital Assets: 0.00
BRNS income_statement (annual, 2025-12-31) — Interest Expense: 51000.00
BRNS income_statement (quarterly, 2025-12-31) — Interest Expense: 13000.00
BRNS income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 51000.00
BRNS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 13000.00
BRNS income_statement (annual, 2025-12-31) — Interest Income: 1957000.00
BRNS income_statement (quarterly, 2025-12-31) — Interest Income: 406000.00
BRNS income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1957000.00
BRNS income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 406000.00
BRNS balance_sheet (annual, 2025-12-31) — Invested Capital: 74208000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 74208000.00
BRNS cash_flow (annual, 2025-12-31) — Investing Cash Flow: 416000.00
BRNS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 2000.00
BRNS cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
BRNS cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Leases: 8910000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Leases: 8910000.00
BRNS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 9258000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 9258000.00
BRNS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9258000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9258000.00
BRNS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 452000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 452000.00
BRNS balance_sheet (annual, 2025-12-31) — Minority Interest: 84000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Minority Interest: 84000.00
BRNS income_statement (annual, 2025-12-31) — Minority Interests: 30000.00
BRNS income_statement (quarterly, 2025-12-31) — Minority Interests: 13000.00
BRNS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
BRNS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
BRNS cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 3742000.00
BRNS cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 59000.00
BRNS income_statement (annual, 2025-12-31) — Net Income: -66428000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Income: -11090000.00
BRNS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -66428000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -11090000.00
BRNS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -66458000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -11103000.00
BRNS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -66428000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -11090000.00
BRNS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -66428000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -11090000.00
BRNS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -66458000.00
BRNS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -11103000.00
BRNS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -66458000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -11103000.00
BRNS income_statement (annual, 2025-12-31) — Net Interest Income: 1906000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Interest Income: 393000.00
BRNS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1906000.00
BRNS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 393000.00
BRNS balance_sheet (annual, 2025-12-31) — Net PPE: 5161000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Net PPE: 5161000.00
BRNS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 416000.00
BRNS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 2000.00
BRNS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 59920000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 59920000.00
BRNS balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 254000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 254000.00
BRNS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 254000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 254000.00
BRNS income_statement (annual, 2025-12-31) — Normalized EBITDA: -56070000.00
BRNS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -10238000.00
BRNS income_statement (annual, 2025-12-31) — Normalized Income: -61774067.60
BRNS income_statement (quarterly, 2025-12-31) — Normalized Income: -11090000.00
BRNS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -47979000.00
BRNS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -4242000.00
BRNS cash_flow (annual, 2025-12-31) — Operating Gains Losses: 3497000.00
BRNS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 163000.00
BRNS income_statement (annual, 2025-12-31) — Operating Income: -63888000.00
BRNS income_statement (quarterly, 2025-12-31) — Operating Income: -11449000.00
BRNS income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
BRNS income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 40848893.00
BRNS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 40848893.00
BRNS balance_sheet (annual, 2025-12-31) — Other Current Assets: 115000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 115000.00
BRNS balance_sheet (annual, 2025-12-31) — Other Equity Interest: 86000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 86000.00
BRNS income_statement (annual, 2025-12-31) — Other Gand A: 40830000.00
BRNS income_statement (quarterly, 2025-12-31) — Other Gand A: 7642000.00
BRNS income_statement (annual, 2025-12-31) — Other Income Expense: -4651000.00
BRNS income_statement (quarterly, 2025-12-31) — Other Income Expense: -104000.00
BRNS cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3409000.00
BRNS cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 585000.00
BRNS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 930000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 930000.00
BRNS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 4347000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4347000.00
BRNS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 16000.00
BRNS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -104000.00
BRNS income_statement (annual, 2025-12-31) — Other Operating Expenses: -506000.00
BRNS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: -8000.00
BRNS balance_sheet (annual, 2025-12-31) — Other Properties: 3390000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Other Properties: 3390000.00
BRNS balance_sheet (annual, 2025-12-31) — Other Receivables: 1108000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 1108000.00
BRNS balance_sheet (annual, 2025-12-31) — Payables: 350000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Payables: 350000.00
BRNS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 6599000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 6599000.00
BRNS balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
BRNS balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 4518000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 4518000.00
BRNS income_statement (annual, 2025-12-31) — Pretax Income: -66633000.00
BRNS income_statement (quarterly, 2025-12-31) — Pretax Income: -11160000.00
BRNS cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 2000.00
BRNS cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Properties: 0.00
BRNS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
BRNS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -37000.00
BRNS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Receivables: 1305000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Receivables: 1305000.00
BRNS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 5845000.00
BRNS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 909000.00
BRNS income_statement (annual, 2025-12-31) — Research And Development: 23564000.00
BRNS income_statement (quarterly, 2025-12-31) — Research And Development: 3815000.00
BRNS balance_sheet (annual, 2025-12-31) — Restricted Cash: 1396000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 1396000.00
BRNS balance_sheet (annual, 2025-12-31) — Retained Earnings: -304092000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -304092000.00
BRNS cash_flow (annual, 2025-12-31) — Sale Of PPE: 453000.00
BRNS cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 2000.00
BRNS income_statement (annual, 2025-12-31) — Selling General And Administration: 40830000.00
BRNS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 7642000.00
BRNS balance_sheet (annual, 2025-12-31) — Share Issued: 40848893.00
BRNS balance_sheet (quarterly, 2025-12-31) — Share Issued: 40848893.00
BRNS income_statement (annual, 2025-12-31) — Special Income Charges: -4667000.00
BRNS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
BRNS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 468000.00
BRNS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 696000.00
BRNS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 74208000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 74208000.00
BRNS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 59920000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 59920000.00
BRNS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -13067.60
BRNS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BRNS income_statement (annual, 2025-12-31) — Tax Provision: -175000.00
BRNS income_statement (quarterly, 2025-12-31) — Tax Provision: -57000.00
BRNS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
BRNS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.01
BRNS balance_sheet (annual, 2025-12-31) — Taxes Receivable: 197000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 197000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Assets: 98169000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Assets: 98169000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Capitalization: 74208000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 74208000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Debt: 11281000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Debt: 11281000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 74292000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 74292000.00
BRNS income_statement (annual, 2025-12-31) — Total Expenses: 63888000.00
BRNS income_statement (quarterly, 2025-12-31) — Total Expenses: 11449000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 23877000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 23877000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 20379000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 20379000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13859000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13859000.00
BRNS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -70555000.00
BRNS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -11565000.00
BRNS balance_sheet (annual, 2025-12-31) — Total Tax Payable: 0.00
BRNS balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 0.00
BRNS income_statement (annual, 2025-12-31) — Total Unusual Items: -4667000.00
BRNS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
BRNS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -4667000.00
BRNS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
BRNS balance_sheet (annual, 2025-12-31) — Working Capital: 67772000.00
BRNS balance_sheet (quarterly, 2025-12-31) — Working Capital: 67772000.00
BRNS income_statement (quarterly, 2026-03-31) — +Operating Expense: 5926000.00
BRNS income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
BRNS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 993000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 394499000.00
BRNS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 40848893.00
BRNS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.14
BRNS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 71852000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 11008000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 65858000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 65858000.00
BRNS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 0.00
BRNS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 55000.00
BRNS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -3366000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 644000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 2586000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -347000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -1046000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Payable: 644000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 3230000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 529000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Receivables: -149000.00
BRNS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2217000.00
BRNS cash_flow (quarterly, 2026-03-31) — Changes In Cash: -3311000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 66399000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 8463000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Current Assets: 72664000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 2005000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2005000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 318000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 318000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 12001000.00
BRNS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -16000.00
BRNS cash_flow (quarterly, 2026-03-31) — Deferred Tax: -16000.00
BRNS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 856000.00
BRNS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 856000.00
BRNS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 40848893.00
BRNS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.14
BRNS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -5531000.00
BRNS income_statement (quarterly, 2026-03-31) — EBIT: -5537000.00
BRNS income_statement (quarterly, 2026-03-31) — EBITDA: -4681000.00
BRNS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -1352000.00
BRNS cash_flow (quarterly, 2026-03-31) — End Cash Position: 67189000.00
BRNS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 0.00
BRNS balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: -18559000.00
BRNS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -3366000.00
BRNS cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: -38000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -18559000.00
BRNS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 2528000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 13666000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4899000.00
BRNS income_statement (quarterly, 2026-03-31) — Interest Expense: 13000.00
BRNS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 13000.00
BRNS income_statement (quarterly, 2026-03-31) — Interest Income: 350000.00
BRNS income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 350000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 66399000.00
BRNS cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 55000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 9003000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 9003000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 79000.00
BRNS income_statement (quarterly, 2026-03-31) — Minority Interests: 3000.00
BRNS cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -1714000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Income: -5531000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -5531000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -5534000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -5531000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -5531000.00
BRNS cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -5534000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -5534000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Interest Income: 337000.00
BRNS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 337000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Net PPE: 4899000.00
BRNS cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: 55000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 52733000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 237000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 237000.00
BRNS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -4681000.00
BRNS income_statement (quarterly, 2026-03-31) — Normalized Income: -5531000.00
BRNS cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -3366000.00
BRNS cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -1752000.00
BRNS income_statement (quarterly, 2026-03-31) — Operating Income: -5926000.00
BRNS income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
BRNS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 40848893.00
BRNS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 194000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 86000.00
BRNS income_statement (quarterly, 2026-03-31) — Other Gand A: 2528000.00
BRNS income_statement (quarterly, 2026-03-31) — Other Income Expense: 39000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 13666000.00
BRNS cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 307000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 914000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 4424000.00
BRNS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 39000.00
BRNS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -46000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Other Properties: 4899000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1232000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Payables: 993000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 9456000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 222000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 3883000.00
BRNS income_statement (quarterly, 2026-03-31) — Pretax Income: -5550000.00
BRNS cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 0.00
BRNS cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: 0.00
BRNS balance_sheet (quarterly, 2026-03-31) — Receivables: 1398000.00
BRNS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 856000.00
BRNS income_statement (quarterly, 2026-03-31) — Research And Development: 3444000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Restricted Cash: 1331000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -309628000.00
BRNS cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 55000.00
BRNS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2528000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Share Issued: 40848893.00
BRNS cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 556000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 66399000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 52733000.00
BRNS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BRNS income_statement (quarterly, 2026-03-31) — Tax Provision: -16000.00
BRNS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
BRNS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 166000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Total Assets: 92143000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 66399000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Total Debt: 11008000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 66478000.00
BRNS income_statement (quarterly, 2026-03-31) — Total Expenses: 5926000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 25665000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 19479000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 13664000.00
BRNS income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -6075000.00
BRNS balance_sheet (quarterly, 2026-03-31) — Working Capital: 60663000.00
BRO cash_flow (annual, 2021-12-31) — Amortization Of Securities: 100000.00
BRO balance_sheet (annual, 2021-12-31) — Construction In Progress: 0.00
BRO cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of Business: -7100000.00
BRO balance_sheet (annual, 2021-12-31) — Investments And Advances: 31000000.00
BRO cash_flow (annual, 2021-12-31) — Net Foreign Currency Exchange Gain Loss: 500000.00
BRO cash_flow (annual, 2021-12-31) — Net Investment Purchase And Sale: -1600000.00
BRO cash_flow (annual, 2021-12-31) — Net Short Term Debt Issuance: 0.00
BRO balance_sheet (annual, 2021-12-31) — Other Payable: 1470700000.00
BRO balance_sheet (annual, 2021-12-31) — Other Properties: 197000000.00
BRO balance_sheet (annual, 2021-12-31) — Other Short Term Investments: 12900000.00
BRO cash_flow (annual, 2021-12-31) — Purchase Of Investment: -12400000.00
BRO cash_flow (annual, 2021-12-31) — Sale Of Investment: 10800000.00
BRO cash_flow (annual, 2021-12-31) — Sale Of PPE: 16600000.00
BRO cash_flow (annual, 2021-12-31) — Short Term Debt Issuance: 0.00
BRO cash_flow (annual, 2021-12-31) — Short Term Debt Payments: 0.00
BRO income_statement (annual, 2022-12-31) — +Operating Expense: 783000000.00
BRO income_statement (annual, 2022-12-31) — +Total Revenue: 3563000000.00
BRO balance_sheet (annual, 2022-12-31) — Accounts Payable: 286500000.00
BRO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 1473900000.00
BRO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -237000000.00
BRO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 919700000.00
BRO income_statement (annual, 2022-12-31) — Amortization: 147000000.00
BRO cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 147000000.00
BRO cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 147000000.00
BRO income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 147000000.00
BRO cash_flow (annual, 2022-12-31) — Amortization Of Securities: 200000.00
BRO income_statement (annual, 2022-12-31) — Basic Average Shares: 277521000.00
BRO income_statement (annual, 2022-12-31) — Basic EPS: 2.38
BRO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1470000000.00
BRO balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 214900000.00
BRO cash_flow (annual, 2022-12-31) — Capital Expenditure: -52000000.00
BRO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 240900000.00
BRO balance_sheet (annual, 2022-12-31) — Capital Stock: 30300000.00
BRO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 650000000.00
BRO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 662000000.00
BRO cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -120000000.00
BRO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 1726000000.00
BRO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1913000000.00
BRO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 881000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Account Payable: 124000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 37000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -18000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: 651000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 20000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Payable: 124000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 161000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -1000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Receivables: -829000000.00
BRO cash_flow (annual, 2022-12-31) — Change In Working Capital: -16000000.00
BRO cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -829000000.00
BRO cash_flow (annual, 2022-12-31) — Changes In Cash: 694000000.00
BRO balance_sheet (annual, 2022-12-31) — Common Stock: 30300000.00
BRO cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -120000000.00
BRO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 4606600000.00
BRO cash_flow (annual, 2022-12-31) — Common Stock Payments: -123000000.00
BRO income_statement (annual, 2022-12-31) — Cost Of Revenue: 1817000000.00
BRO balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 48100000.00
BRO balance_sheet (annual, 2022-12-31) — Current Assets: 4996000000.00
BRO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 45000000.00
BRO balance_sheet (annual, 2022-12-31) — Current Debt: 250600000.00
BRO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 295600000.00
BRO balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 492200000.00
BRO balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 492200000.00
BRO balance_sheet (annual, 2022-12-31) — Current Liabilities: 4596600000.00
BRO balance_sheet (annual, 2022-12-31) — Current Provisions: 880300000.00
BRO cash_flow (annual, 2022-12-31) — Deferred Income Tax: 43000000.00
BRO cash_flow (annual, 2022-12-31) — Deferred Tax: 43000000.00
BRO cash_flow (annual, 2022-12-31) — Depreciation: 39000000.00
BRO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 186000000.00
BRO income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 186000000.00
BRO cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 186000000.00
BRO income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 186000000.00
BRO income_statement (annual, 2022-12-31) — Depreciation Income Statement: 39000000.00
BRO income_statement (annual, 2022-12-31) — Diluted Average Shares: 278658000.00
BRO income_statement (annual, 2022-12-31) — Diluted EPS: 2.37
BRO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 659000000.00
BRO income_statement (annual, 2022-12-31) — EBIT: 1024000000.00
BRO income_statement (annual, 2022-12-31) — EBITDA: 1210000000.00
BRO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -131000000.00